| Primary |
| Product Used For Unknown Indication |
100.0% |
|
| Haemorrhage Intracranial |
50.0% |
| Rash |
50.0% |
|
| Secondary |
| Hypertension |
43.3% |
| Essential Hypertension |
9.7% |
| Product Used For Unknown Indication |
8.3% |
| Drug Use For Unknown Indication |
6.9% |
| Diabetes Mellitus |
4.1% |
| Depression |
3.7% |
| Ill-defined Disorder |
3.7% |
| Trigeminal Neuralgia |
2.8% |
| Dyslipidaemia |
2.3% |
| Insomnia |
2.3% |
| Atrial Fibrillation |
1.8% |
| Epilepsy |
1.8% |
| Angina Pectoris |
1.4% |
| Blood Pressure |
1.4% |
| Hyperlipidaemia |
1.4% |
| Prophylaxis |
1.4% |
| Anxiety |
0.9% |
| Atrial Flutter |
0.9% |
| Constipation |
0.9% |
| Crohn's Disease |
0.9% |
|
| Ventricular Hypertrophy |
10.0% |
| Electrocardiogram Qt Prolonged |
7.5% |
| Gingival Bleeding |
7.5% |
| Headache |
7.5% |
| Rash Scarlatiniform |
7.5% |
| Renal Failure Acute |
7.5% |
| Rhabdomyolysis |
7.5% |
| Malaise |
5.0% |
| Orthostatic Hypotension |
5.0% |
| Somnolence |
5.0% |
| Swollen Tongue |
5.0% |
| Vomiting |
5.0% |
| Blindness Unilateral |
2.5% |
| Expired Drug Administered |
2.5% |
| Head Injury |
2.5% |
| Hydrocephalus |
2.5% |
| Hypertension |
2.5% |
| International Normalised Ratio Increased |
2.5% |
| Leukocytoclastic Vasculitis |
2.5% |
| Loss Of Consciousness |
2.5% |
|
| Concomitant |
| Hypertension |
32.3% |
| Drug Use For Unknown Indication |
13.6% |
| Product Used For Unknown Indication |
13.0% |
| Atrial Fibrillation |
6.2% |
| Diabetes Mellitus |
4.7% |
| Breast Cancer |
4.6% |
| Type 2 Diabetes Mellitus |
2.7% |
| Essential Hypertension |
2.5% |
| Pain |
2.4% |
| Multiple Myeloma |
2.1% |
| Pneumonia |
2.1% |
| Hiv Infection |
1.9% |
| Hypercholesterolaemia |
1.7% |
| Prostate Cancer |
1.7% |
| Thrombosis Prophylaxis |
1.7% |
| Acute Coronary Syndrome |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Hepatitis C |
1.4% |
| Erysipelas |
1.3% |
| Lymphoma |
1.3% |
|
| Vomiting |
8.0% |
| Renal Failure |
6.8% |
| Syncope |
6.8% |
| Deep Vein Thrombosis |
5.7% |
| Hyponatraemia |
5.7% |
| Renal Failure Acute |
5.7% |
| Renal Impairment |
5.7% |
| Transaminases Increased |
5.7% |
| Blood Pressure Decreased |
4.5% |
| Death |
4.5% |
| Myocardial Ischaemia |
4.5% |
| Pneumonia |
4.5% |
| Prothrombin Time Shortened |
4.5% |
| Stomatitis |
4.5% |
| Transient Ischaemic Attack |
4.5% |
| Ulcerative Keratitis |
4.5% |
| Blood Pressure Increased |
3.4% |
| Cerebrovascular Accident |
3.4% |
| Hypertension |
3.4% |
| Interstitial Lung Disease |
3.4% |
|
| Interacting |
| Hypertension |
52.6% |
| Trigeminal Neuralgia |
10.5% |
| Angina Pectoris |
5.3% |
| Depression |
5.3% |
| Hypercholesterolaemia |
5.3% |
| Hyperlipidaemia |
5.3% |
| Insomnia |
5.3% |
| Prophylaxis |
5.3% |
| Traumatic Haematoma |
5.3% |
|
| Drug Interaction |
33.3% |
| Left Ventricular Hypertrophy |
33.3% |
| Varicose Ulceration |
33.3% |
|
